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Functional Analysis of the Role of Toxoplasma gondii Nucleoside
Triphosphate Hydrolases I and II in Acute Mouse Virulence and
Immune Suppression
Philipp Olias, L. David Sibley
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA
Bioluminescent reporter assays have been widely used to study the effect of Toxoplasma gondii on host gene expression. In the
present study, we extend these studies by engineering novel reporter cell lines containing a gamma-activated sequence (GAS)
element driving firefly luciferase (FLUC). In RAW264.7 macrophages, T. gondii type I strain (GT1) infection blocked interferon
gamma (IFN-)-induced FLUC activity to a significantly greater extent than infection by type II (ME49) and type III (CTG)
strains. Quantitative trait locus (QTL) analysis of progeny from a prior genetic cross identified a genomic region on chromo-
some XII that correlated with the observed strain-dependent phenotype. This QTL region contains two isoforms of the T. gondii
enzyme nucleoside triphosphate hydrolase (NTPase) that were the prime candidates for mediating the observed strain-specific
effect. Using reverse genetic analysis we show that deletion of NTPase I from a type I strain (RH) background restored the higher
luciferase levels seen in the type II (ME49) strain. Rather than an effect on IFN--dependent transcription, our data suggest
that NTPase I was responsible for the strain-dependent difference in FLUC activity due to hydrolysis of ATP.We further show
that NTPases I and II were not essential for tachyzoite growth in vitro or virulence in mice. Our study reveals that although T.
gondiiNTPases are not essential for immune evasion, they can affect ATP-dependent reporters. Importantly, this limitation was
overcome using an ATP-independent Gaussia luciferase, which provides a more appropriate reporter for use with T. gondii in-
fection studies.
Toxoplasma gondii is an obligate intracellular protozoan para-site that can infect virtually all warm-blooded animals and
humans (1). It is the cause of toxoplasmosis, a serious infectious
disease in congenitally infected children and immunosuppressed
individuals (2), and an important pathogen in livestock (3). In-
nate immunity provides a critical defense barrier against T. gondii
infection and interferon gamma (IFN-) plays a key role in this
defense (4). In IFN--activated cells, the transcription factor sig-
nal transduction and activator of transcription factor 1 (STAT1)
translocates to the nucleus and binds as a homodimer to gamma-
activated sequence (GAS) sites in promoters of IFN--responsive
genes such as IFN regulatory factor 1 (IRF1), major histocompat-
ibility complex type II (MHC-II), or immunity-related GTPases
(5). IRF1 is an early response gene of the STAT1 pathway and a
transcription coactivator of genes induced by IFN- (6). Over the
past few years, multiple virulence factors of the parasite have been
identified that work in concert to block effectors that have been
preactivated by IFN- and which are upregulated by the STAT1
pathway (7). Central is the effector rhoptry protein 18, which has
been identified as a major virulence determinant in the mouse by
quantitative trait locus (QTL) analysis based on genetic crosses
betweenT. gondii strains (8, 9). Virulent type I strains also contain
a unique isoform of a nucleoside triphosphate hydrolase (NT-
Pase) I, whereas NTPase II is universally present in all T. gondii
strains (10). This difference has led to the speculation that NTPase
I might also constitute an important virulence factor, and this
possibility is supported by the fact that attempts to knock out
NTPase I have been unsuccessful so far (11). The biological roles
of NTPases I and II, however, still remain unknown. Interestingly,
although these enzymes have only 16 amino acid differences be-
tween them (10), NTPase I preferentially hydrolyzes triphosphate
nucleosides, while NTPase II hydrolyzes tri- and diphosphate
nucleosides (10). Additionally, NTPase I cleaves ATP at 4.5 times
the rate of NTPase II (10, 12). In vitro, it has been shown that
dithiol compounds such as dithiothreitol (DTT) are essential for
activation of the NTPases (13).
In cells that are infected prior to IFN- activation, T. gondii
blocks IFN--dependent gene transcription by an unknown effec-
tor mechanism (14, 15). This inhibition occurs independent of
cell type in both mouse and human cells as shown by the inhibi-
tion of multiple genes that are upregulated by the STAT1 pathway
such as IRF1, MHC-II, MHC transactivator (CIITA), and induc-
ible nitric oxide synthase (i.e., the NOS2 gene) (14–16). Recently,
a GAS element driven firefly luciferase (FLUC) reporter was used
to measure strain-dependent inhibition in HEK293 cells treated
with IFN-. Interestingly, no difference was detected between the
three main clonal T. gondii lineage types I, II, and III (17), a find-
ing consistent with previous transcriptional studies indicating
that all three strain types suppress IFN--dependent transcription
(14, 15).
In the present study, we identified a strain-dependent differ-
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ence using a similar GAS-driven FLUC reporter in RAW264.7
macrophages and HeLa cells. We identified the genomic locus
responsible for the observed phenotype by QTL analysis of a pre-
vious genetic cross and generated disruptant mutants of the two
most likely candidate genes of that locus: NTPase I andNTPase II.
However, rather than being due to a transcriptional difference,
our studies show that the FLUC assay is prone to artifacts due to
the strong ATP hydrolysis activity of NTPases. This problem was
circumvented by using a Gaussia luciferase (GLUC) that does not
rely on ATP, thus confirming that all three strain types ofT. gondii
block IFN--mediated transcription via STAT1.
MATERIALS AND METHODS
Parasite and host cell strains.Toxoplasma gondii strains weremaintained
as tachyzoites by serial passage on human foreskin fibroblast (HFF) cell
monolayers in regular growth media based on Dulbecco modified Eagle
medium (Life Technologies, Carlsbad, CA) supplemented with 10% fetal
bovine serum (FBS; Thermo Fisher Scientific, Waltham, MA), 2 mM
L-glutamine, 10mMHEPES (pH 7.5), and gentamicin (20g/ml) at 37°C
under 5%CO2. Parasites used in experiments were harvested after natural
egress and separated from host cell debris by a 3-m-pore-size nucleo-
pore filter.T. gondiiGT1 (ATCC50853; type I),ME49 (ATCC50611; type
II), and CTG (ATCC 50842; type III) were used as representative type
strains. A collection of progeny from a previous genetic cross between I
(GT1SNFr) II (ME49FUDRr) strains (18) was used for QTLmapping. RH
(type I) strain expressing green fluorescent protein (GFP) (RHhxgprt/
GFP; ATCC 50940) was used for the construction of CRISPR/Cas9 (19)
guided NTPase I and II gene disruptant mutants. All parasite strains and
cell lines were routinely diagnosed negative for Mycoplasma contamina-
tion using the e-Myco plus mycoplasma PCR detection kit (Boca Scien-
tific, Boca Raton, FL).
Reporter cell line construction.All plasmids and primers used in this
study are listed inTables S1 to S3 in the supplementalmaterial. RAW264.7
macrophages andHeLa cells were transducedwith lentiviral particles con-
taining four tandem GAS elements (5=-AGTTTCATATTACTCTAAAT
C-3=) fused to a murine cytomegalovirus (mCMV) promoter driving a
FLUC (pGreenFire1-GAS-EF1-puro; System Biosciences, San Francisco,
CA). Permanent cell lines were established under puromycin selection
and single colonies were selected for activation by IFN-. Gibson assem-
bly (Gibson assembly cloning kit; NEB, Ipswich, MA) was used to con-
struct the GLUC expression vector. In short, five tandem GAS elements
were fused to a mCMV promoter that is driving GLUC. A neomycin
resistance cassette was added for stable cell transfection (pGLUC-
5GAS-mCMV-neoR). After transfection into RAW264.7 macrophages
with Lipofectamine LTX (Thermo Fisher Scientific, Waltham, MA), sta-
ble colonies were selected under G418 (Sigma, St. Louis, MO) and tested
for activation of GLUC by IFN-.
FLUC and GLUC reporter assays. Reporter cells were plated into
black 96-well plates with clear bottoms (BD Biosciences, Franklin Lakes,
NJ) in regular growthmedia. Confluentmonolayers were infected in trip-
licate with parasites at various multiplicities of infection (MOIs). At 2 h
after infection, the cells were activated with 100 U of murine and human
IFN-/ml, respectively, for 18 h. Cells containing FLUCwerewashed once
with phosphate-buffered saline (PBS) and lysed with either cell culture
lysis reagent (Promega, Madison, WI) or dithiothreitol (DTT)-free stan-
dard lysis buffer (100mMpotassium phosphate [pH 7.8], 1 mMEDTA, 7
mM 2-mercaptoethanol, 10% [vol/vol] glycerol) (20). Cells containing
GLUCwere lysedwith luciferase cell lysis buffer (NEB). The luminescence
intensity was measured after the addition of 100 l of firefly luciferase
assay substrate (Promega) after the addition of 50l ofGaussia luciferase
assay buffer (NEB), according to the manufacturer’s instructions. Lumi-
nescence was detected on a Cytation 3 Cell Imaging Multi-Mode plate
reader (Biotek, Winooski, VT), and data were normalized to the unin-
fected, stimulated sample. For strain comparisons, we used the mean lu-
minescence value generated at an MOI, at which the infection rate was
50% as determined by a quantitative invasion assay (21) that was per-
formed in parallel. Samples were averaged over two to three biological
replicates, each with three technical replicates.
QTL analysis. For QTL association mapping, the ability of strains to
interfere with the FLUC reporter system in RAW264.7 macrophages was
expressed as a ratio of the uninfected, activated control. Each strain was
measured at a range of five different MOIs in triplicate using a 96-well
plate format. At 2 h after infection, the cells were activated with 100 U of
IFN-/ml overnight for 18 h, after which the cells were lysed with lysis
buffer (Promega), and the luciferase activity was measured. Log(1/P) val-
ues were plotted along the genome-wide coordinates of the 1,603 single nu-
cleotide polymorphism markers described previously (18), with genome-
wide significance thresholds determined from 1,000 permutations. For fine
mapping the region in the identifiedQTL, we isolated and characterized new
progeny from a previous genetic cross (18). These new progeny clones were
typedwithmarkers on chromosomeXII using previously publishedmarkers
(22) and at new genomic regions that were PCR amplified and sequenced
with newly designed primers (see Table S2 in the supplemental material).
Single nucleotide polymorphisms within these new markers were used to
genotype the progeny with respect to the parental alleles.
CRISPR/Cas9-mediated generation of NTPase disruptant mutants.
For disruption of the NTPase locus, two CRISPR/Cas9 plasmids contain-
ing specific guide RNA sequences (see Table S3 in the supplemental ma-
terial) matching either NTPase I or NTPase II were constructed by Q5
polymerase PCR mutagenesis (NEB), as described previously (19). After
transfection of the plasmids, together with amplicons containing either
hypoxanthine, xanthine, guanosine, phosphoribosyl transferase (HXG-
PRT), or dihydrofolate reductase (DHFR) by electroporation, transgenic
parasites were selected inmycophenolic acid (25g/ml) and xanthine (50
g/ml) and 3 mM pyrimethamine, respectively. Single-cell clones were
obtained by limiting dilution, and gene disruption was verified by diag-
nostic PCR using primers listed in Table S3 in the supplemental material.
PCRs were performed using Taq DNA polymerase (Sigma). Products
were analyzed by electrophoresis in agarose gels with ethidium bromide.
Western blot analysis. PCR-positive clones were further analyzed by
Western blotting to confirm the absence of NTPase protein. In brief, T.
gondii tachyzoite lysates were resolved on SDS-PAGE gels and subse-
quently transferred to nitrocellulose. Blotted proteins were blocked in
LICOR blocking buffer (LICOR Biosciences, Lincoln, NE) and detected
with rabbit anti-NTPase (23) and mouse anti-GRA7 (24) primary anti-
bodies incubated in 5%milk in PBS for 1 h. Secondary antibodies (LICOR
Biosciences) conjugated to IRDye 680CW (donkey anti-rabbit IgG) and
IRDye 800CW (donkey anti-mouse IgG) were used to visualize signals on
an Odyssey infrared imager (LICOR Biosciences).
Plaque and mouse virulence assay.Mice were kept in an Association
for Assessment and Accreditation of Laboratory Animal Care-approved
facility. The Institutional Care Committee at Washington University
School of Medicine approved all experiments. Groups of five female CD1
micewere injected intraperitoneally with 200 parasites. The survival of the
animalswasmonitored over 30 days. The animal experimentwas repeated
once, and the cumulative mortality of both experiments (n 10mice per
group) was plotted as Kaplan-Meyer curves in Prism (GraphPad Soft-
ware, Inc., La Jolla, CA), as previously described (7). To test for parasite
viability, parasites were inoculated onto HFF cell monolayers grown in
six-well plates for 7 days without movement. Subsequently, cells were
fixed with 70% ethanol and stained with 0.1% crystal violet. Plates were
then scanned using an Epson scanner.
Immunofluorescence assay. To assess the inhibition of the STAT1
pathway by the wild type and by NTPase disruptant mutants, HFF cells
were infected for 16 h and subsequently activated with 100 U of IFN-/ml
for 5 h. The cells were fixed with 4% formaldehyde in PBS for 15 min,
permeabilized with 0.1% Triton X-100 for 15 min at room temperature,
and blocked in 10% FBS for 20 min. Subsequently, samples were incu-
bated with anti-IRF1 (Cell Signaling, Danvers, MA), washed in PBS, and
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incubated with secondary goat anti-rabbit IgG conjugated to Alexa Fluor
594 dye (Invitrogen, Carlsbad, CA). After staining, the slides were
mounted with Prolong Gold plus DAPI (4=,6=-diamidino-2-phenylin-
dole; Life Technologies) and examined with a Zeiss Axioskop 2MOTPlus
microscope equipped for epifluorescence and using a 63 PlanApochro-
mat lens (numerical aperture [N.A.] of 1.40; Carl Zeiss, Inc., Thornwood,
NY). Images were acquired with an AxioCam MRm camera (Carl Zeiss)
using Axiovision and processed with Gimp 2.8. The mean red fluores-
cence of IRF1 in host cell nuclei was determined by the use of the ROI
manager in ImageJ. A region of interest (ROI) was selected over DAPI-
stained host cell nuclei and the unstained background. The corrected
integrated density (CTCF) representing nuclear red fluorescence was cal-
culated by using the following equation: CTCF  integrated density –
(area of nucleusmean fluorescence of background readings). Prism v6
(GraphPad) was used for blotting the results of three biological replicates,
each with 15 technical replicates per condition.
Statistics. Statistical analyses were conducted with Prism v6. The re-
sults were compared using the Kruskal-Wallis test or two-sample Student
t tests, as noted (*, P  0.05 was considered the minimum cutoff for
significance).
RESULTS
Strain-dependent interference with GAS-FLUC assay. Clonal
type strains of T. gondii (i.e., types I, II, and III) have previously
been reported to equally interfere with the STAT1 signaling path-
way and thereby block IFN--dependent gene expression (15, 17).
The exactmechanism of this block is still unknown despite several
attempts to identify aT. gondii effector over the past 2 decades. To
investigate the mechanism of STAT1 inhibition by T. gondii, we
adopted a FLUC reporter system for use in HeLa cells and
RAW267.4 macrophages. At a lowMOI, we were unable to detect
a significant strain-dependent difference in HeLa cells, a finding
consistent with previous reports (17). However, at higher MOIs,
the strain GT1 blocked the reporter system more efficiently than
eitherME49 or CTG (Fig. 1A).More dramatically, a strong strain-
dependent effect was detected even at lower infection rates in
RAW267.4 macrophages (Fig. 1B). These results led us to suspect
that previous studies had failed to observed a strain-dependent
effect either due to use of different reporter cell lines, lowerMOIs,
or a combination of effects.
QTL analysis maps to a single locus on chromosome XII. To
investigate the observed strain-dependent effect further and to test
whether the phenotype could be mapped to a genomic region, we
took advantage of a previously established cross between GT1 and
ME49 strains (18). We determined the ratio of IFN--dependent
FLUCactivity from infected versus noninfected cells for each of 36
recombinant progeny (Fig. 2A). The parental GT1 strain strongly
interferedwith the FLUC signal, whereas the parentalME49 strain
was only weakly inhibitory (Fig. 2A). Interestingly, almost all
clones clustered close to one of the parental lineages, suggesting
that a single genomic locus was responsible for the observed phe-
notype. We analyzed the interference of FLUC activation as a
quantitative trait andmapped the locus to a region of688 kb on
the right side of chromosome XII (Fig. 2B). Initially, this region
was bounded by recombination between markers 181 and 193, as
typified by progeny SF50 and SF34 (Fig. 2B). In order to narrow
down the region, we identified two new progeny from this cross
(i.e., 2C7C3 and SF59) that were genotyped using a previous set of
markers, as well as new geneticmarkers defined by direct sequenc-
ing of regions within this locus (Fig. 2C). Collectively, the cross-
overs defined by these progeny identify a region of 263 kb
(TGME49_chrXII: 6559896.0.6822749) on chromosomeXII con-
taining 36 genes (http://ToxoDB.org) that was associated with the
observed phenotype (Fig. 2C). Robust multiarray averaging
(RMA) comparison for expression differences between GT1 and
ME49 (25) across this region identified nucleoside triphosphate
hydrolase (NTPase) as differentially expressed with higher levels
being detected in the type I GT1 strain. Closer inspection revealed
that this difference in expression occurred because of differences
in gene copy number. Specially, NTPase I is only present in type I
strains, while NTPase II is found in type I and other strains such as
ME49 (10) (Fig. 3A). Additionally, the type I locus also contains a
pseudogene that is not expressed (Fig. 3A).
Generation of NTPase single- and double-disruptant mu-
tants. To verify that the NTPase locus was responsible for the
mapped phenotypic difference, we used CRISPR/Cas9 technology
(19) to generate single- and double-gene disruptant mutants in
the type I RH strain. Initially, we used aDHFR cassette that confers
FIG 1 Toxoplasma gondii strain-dependent inhibition of luminescence in IFN--inducible FLUC reporter lines. A tandem GAS element-driven FLUC reporter
was stably expressed in HeLa cells (A) or RAW264.7 macrophages (B). Reporter cell lines were plated in 96-well plates and infected with different MOIs, as
indicated. At 2 h after infection, the cells were stimulated with 100 U of IFN-/ml for 18 h. Subsequently, the cells were lysed, and the luciferase activity was
measured. The data shown are means 	 standard errors of the mean (SEM) of at least three independent experiments, each with three technical replicates.
Kruskal-Wallis test with Dunn’s correction (***, P 0.0001) was performed for GT1 and each of the other T. gondii strains.
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resistance to pyrimethamine to isolate a gene disruptant mutant
lacking eitherNTPase I (ntpase I; RHhxgprt/ntpaseI::DHFR) or
NTPase II (ntpase II; RHhxgprt/ntpaseII::DHFR) (Fig. 3A).
Subsequently, a double-disruptant mutant was generated using
anHXGPRT resistance cassette inserted into the NTPase I gene
in the ntpase II background (ntpase II ntpase I; RHhxgprt/
ntpaseII::DHFR/ntpaseI::HXGPRT). All mutants were confirmed
by diagnostic PCR (Fig. 3B). To confirm the absence of protein
products in the single or double gene knockouts, we used a poly-
clonal rabbit antibody that has been raised previously against the
full-lengthNTPase II protein (23).Western blot data indicate that
in the RH strain NTPase I is more abundant than NTPase II (Fig.
3C). We independently generated a second version (v2) double-
knockout clone using HXGPRT resistance cassette as an insert
(ntpase IIntpase I v.2, RHhxgprt/ntpaseII::HXGPRT/ntpaseI::
HXGPRT) (Fig. 3A).
Knockouts of NTPase II and I are not essential for growth or
virulence in CD1 mice and do not affect STAT1 transcription.
Since NTPase I is present in type I strains (10), it has been specu-
lated that NTPase I is a primary virulence factor (11). Notably, we
were not able to identify any growth defect in either of the single or
double knockouts in vitro (Fig. 4A). To test whether the absence of
NTPase I or NTPase II, as well as the disruption of both genes,
would have a virulence defect in vivo, we infected CD1 mice. No
significant difference in survival was identified between single and
double knockouts compared to wild-type RH (Fig. 4B). To test
whether NTPase I and NTPase II interfere with the STAT1 path-
way, we used IRF1 as IFN--inducible protein marker. Normally,
IRF1 is upregulated by STAT1-mediated transcription, and it ac-
cumulates in the nucleus after treatment with IFN-; this pathway
is blocked by prior infectionwithT. gondii (15). Unexpectedly, we
could not identify any difference in the ability to block the IRF1
induction between wild-type RH compared to single and double
NTPase disruptant mutants (Fig. 4C). This finding suggested that
any potential effects of NTPases on the FLUC assay were not due
to disruption of STAT1-mediated transcription but rather to
some interference in the assay.
NTPases I and II were responsible for the ATP-dependent
artifact in firefly luciferase assay. To examine the role of NTPase
enzymes in luciferase assays, we compared wild-type and mutant
lines in the reporter cell assays. We observed a strong negative
influence of NTPase I on the FLUC activity in bothHeLa cells and
RAW264.7 macrophages (Fig. 5A and B). Notably, the NTPase I
knockout in the type I strainmirrors the less inhibitory phenotype
of type II (ME49) and III (CTG) strains, which naturally lack
NTPase I (Fig. 5A and B). In contrast, deletion of NTPase II
showed only a mild change in inhibition of the FLUC assay (Fig.
5A and B). Furthermore, the inhibitor effect of NTPases on the
FLUC assay was partially rescued by adding 20 mM ATP during
host cell lysis and by the absence of dithiol compounds, respec-
tively (Fig. 5C). These findings suggest that the inhibition of FLUC
activity is due to consumption of ATP by the NTPases.
To overcome the limitation of FLUC assays, we implemented
the ATP-independent GLUC as an alternative reporter. Using this
ATP-independent system, the original strain-dependent differ-
ence in luciferase activity was no longer apparent. Moreover,
when we compared the NTPase disruptant mutants, they showed
no difference from wild-type T. gondii parasites (Fig. 5D).
DISCUSSION
In this study, we aimed to identify T. gondii effectors responsible
for blocking the IFN- immune response in host cells. Previously,
it has been shown that T. gondii inhibits STAT1-mediated tran-
scription in IFN--activated cells and that different clonal parasite
strain types do so with similar efficiency (15, 17). We developed
multiple GAS-FLUC reporter lines in human andmouse cells and
contrary to previous studies uncovered a strain-dependent inhi-
bition of IFN- signaling. Initially, we attributed this difference to
different reporter cell lines or to the higher MOIs used in our
studies. Based on observing a strong strain-specific difference in
the inhibition of FLUC activity in RAW264.7 macrophages, we
reasoned that this trait was amenable to QTL analysis. We took
advantage of a previous genetic cross (18) and analyzed recombi-
nant progeny based on their ability to inhibit IFN--driven GAS-
FLUC activity in infected macrophages.
Using QTL analysis, we mapped the strain-dependent pheno-
type to a single locus containing theNTPase I andNTPase II genes,
which have previously been implicated in virulence (10, 11). After
FIG 2 Mapping of a single target locus on chromosome XII. (A) GT1 (type I) andME49 (type II) parental strains and 36 progeny were tested for their ability to
interfere with the GAS-FLUC in RAW264.7 macrophages. The data shown are normalized averages of three technical replicates	 standard deviations (SD). (B
and C) QTL scan of normalized percent inhibition identified a single locus of688 kb (TGME49_chrXII: 6134501.0.6822749) on chromosome XII defined by
the twomarkers 181 and 193 and the progeny SF50 and SF34. Finemapping with additional PCRmarkers (see Table S2 in the supplemental material) within the
QTL identified two additional informative progeny (2C7C3 and SF59) and narrowed the region responsible for the observed strain difference to 263 kb
(TGME49_chrXII: 6559896.0.6822749) comprising 36 annotated genes.
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FIG 3 Generation and verification of NTPase I and II single- and double-disruptantmutants. (A)Diagram of single NTPase II (ntpase II; RHhxgprt/ntpaseII::
DHFR) andNTPase I (ntpase I; RHhxgprt/ntpaseI::DHFR)mutants and two versions of double-knockoutmutants (ntpase IIntpase I, RHhxgprt/ntpaseII::
DHFR/ntpaseI::HXGPRT; ntpase II ntpase I v.2, RHhxgprt/ntpaseII::HXGPRT/ntpaseI::HXGPRT) generated by CRISPR/Cas9 guided gene disruption. The
pseudogene (PG) lacks a suitable start codon and therefore is not transcribed (30). However, it shares complete sequence homology in part with either NTPase
II or I for which reason the guide RNA II targets bothNTPase II and the pseudogene resulting in a double cut. The type I RH strain (hxgprt) was the background
for all themutants described. For the locations and sequences of guides, see Table S3 in the supplementalmaterial. (B)Diagnostic PCRof disruptantmutantswith
primer pair locations as indicated in panel A. For primer locations and sequences, see Table S3 in the supplemental material. (C)Western blot analysis of protein
loss in NTPase disruptant mutants. GRA7 served as loading control.
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we identified theQTLon chromosomeXII, we narrowed the locus
to a region containing 36 genes. Based on detecting a higher level
of gene expression in the type I GT1 lineage, we reasoned that the
NTPase I and NTPase II genes might indeed be involved in this
phenotype. NTPase I is found only in virulent type I strains
(10), and previous studies have suggested it is refractory to
deletion (11), suggesting that it might play a role in acute vir-
ulence. NTPases I and II are located in dense granules and
constitute 2 to 8% of the total tachyzoite protein content (12,
13, 26). It has previously been reported that NTPases might be
involved in tachyzoite egress or purine salvage (27). However, it is
unclear how theNTPasesmight affect STAT1 signaling, since both
enzymes are not thought to be released into the host cell cytosol
but rather occupy the parasitophorous vacuole (23).
Despite previous predictions, deletion of the genes encoding
either or both of the NTPase enzymes had no effect on growth or
virulence of T. gondii. Using the highly efficient CRISPR/Cas9
system (19), wewere easily able to delete each of theNTPase genes,
as well as generate the double mutant using several different strat-
egies. Although these findings do not rule out another role in
different life cycle stages or different hosts, it is apparent they are
not essential under normal growth conditions or in the murine
model. However, we did confirm that the presence of NTPase I
was associated with greater inhibition of the FLUC assay, thus
FIG 4 Growth, virulence, and interference with STAT1 pathway. (A) Plaque assay on HFF monolayers examining growth of wild-type and NTPase knockout
parasites. (B) Virulence of NTPase knockout strains in CD-1mice infected intraperitoneally with 200 tachyzoites per mouse. Groups of fivemice per strain were
infected, and the survival wasmonitored. The experiment was repeated once, and the results of both experiments were plotted together. (C) A fluorescence assay
performed to examine the interference of wild-type T. gondiiwith IRF1 protein expression as a readout for STAT1-activated transcription compared to NTPase
knockout strains showed no NTPase-dependent effect. HFF monolayers were infected for 2 h and subsequently activated with 100 U of IFN-/ml for 5 h.
Quantification of the IRF1fluorescence of infected cells versus controls. Data points represent themean red fluorescence in aROI overlaying the host cell nucleus.
IRF1, red; DAPI, blue; T. gondii-GFP, green. Scale bar, 10 m. ***, P 0.0001 (Kruskal-Wallis with Dunn’s correction).
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supporting the original strain-dependent difference we observed.
Consistent with ourQTLmapping result, deletion of theNTPase I
gene in the type I RH strain restored levels of FLUC to levels
similar to the ME49 strain, which contains only NTPase II. How-
ever, the inhibitory effect observed in the FLUC assay was not due
to blockage of STAT1-induced transcription, as shown by the in-
duction of IRF1 in an immunofluorescence assay. Transcription
of IFN--inducible genes such as IRF1 is initiated after phosphor-
ylated STAT1 homodimers bind to gamma-activated sequence
(GAS) elements in their promoter regions (28). Since IFN--de-
pendent transcription is globally blocked in T. gondii-infected
cells (15, 29), we would have expected this block to be absent in
NTPase knockout strains if these genes were responsible. How-
ever, when we examined the ability of NTPase mutants to inhibit
STAT1-induced gene expression, we found that the loss of both
enzymes had no effect. This result led us to suspect that the inhi-
bition of FLUC activity was due to the potent activity of NTPase I
in consuming ATP, which is necessary for initiation of the light
reaction in several luciferase systems, such as FLUC and click bee-
tle luciferase.
Taken together, the combination of QTLmapping and reverse
genetic approaches using CRISPR/Cas9 confirmed that type I
strains inhibit FLUC to a greater extent and that theNTPase genes
were responsible for this trait. However, the failure of NTPase
mutants to alter IRF1 induction suggested that the original
FLUC assay was not a faithful readout for STAT1 activity. In-
stead, our findings strongly suggest that ATP hydrolysis by T.
gondiiNTPases was responsible for the observed interference with
the FLUC assay. This conclusion is supported by the presence of
NTPase I, which is more strongly expressed and has a higher ATP
hydrolysis rate, in type I strains that show greater potential to
inhibit the FLUC assay. Additional support is provided by the fact
that NTPase activity was enhanced by dithiol compounds such as
DTT (13), a component of our FLUC assay, and addition of ATP
FIG 5 Influence of NTPases I and II on firefly and Gaussia luciferase reporter lines. IFN--inducible tandem GAS element-driven FLUC reporter lines were
infectedwith differentMOIs for 3 h and subsequently stimulatedwith 100Uof IFN-/ml for 18 h. NTPase I and double-knockoutmutants were significantly less
capable at suppressing FLUC activity in both RAW264.7 macrophages (A) and HeLa cells (B) than the wild-type RH strain. Asterisks (*) indicate a P value
of0.05 between the wild type and NTPase I and double-knockout mutants. (C) The addition of ATP during cell lysis or the absence of DTT in the lysis buffer
partially reversed the interference with the firefly luciferase reporter. Asterisks (*) indicate a P value of 0.05 between cell lysis with or without DTT. (D) An
IFN--inducible tandem GAS element-driven ATP-independent GLUC RAW264.7 macrophage reporter line showed no NTPase-dependent effect. The data
shown are averages	 SEM of at least three independent experiments, each performed with three technical replicates (A, C, and D), and averages	 SD of two
independent experiments with three technical replicates (B).
Olias and Sibley
2000 iai.asm.org July 2016 Volume 84 Number 7Infection and Immunity
 o
n
 July 23, 2016 by W







during cell lysis or DTT-free lysis buffer partially reversed the
inhibition of FLUC activity by T. gondii.
Notably, the enzymatic effect of NTPases was independent of
the species or cell type background of the reporter assay, as re-
flected by very similar results in both murine RAW264.7 macro-
phages and humanHeLa cells. Hence, the artifact described here is
likely to confound other ATP-dependent assays involving T. gon-
dii infection of host cells. Although the use ofT. gondii strains null
for both NTPase I and NTPase II could be used to avoid interfer-
ence artifacts in ATP-dependent assays, the use of a non-ATP-
dependent luciferase such as Gaussia luciferase avoids this prob-
lem. Therefore, theGaussia luciferase assay provides the preferred
platform for future studies on gene expression inhibitor screening
and growth assays involving T. gondii.
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